Explore the Latest Infliximab Tenders on Tender Impulse - Your Trusted Global Tender Website
Are you searching for the latest Infliximab Tenders from trusted sources across the globe? Tender Impulse is the go-to tender website for businesses seeking verified, timely updates on public tenders, government tenders and business tenders.
With real-time data and smart filters, you can find the most relevant Infliximab Tenders issued by ministries, public sector organisations and international procurement agencies - whether you're an SME or a multinational.
All-in-One Platform for Infliximab Tenders
- Requests for Proposals (RFPs) & Quotations (RFQs)
- General Procurement Notices (GPNs) & Expressions of Interest (EOIs)
- Prequalification documents, contract awards and amendments
Why Choose Tender Impulse?
- Custom email alerts tailored to your industry.
- Global coverage across 190+ countries and every major sector.
- Instant document access - specifications, BOQs and tender forms.
- Advanced filters by country, industry, deadline, value and procurement type.
Request a free live demo today and explore thousands of Infliximab Tenders and beyond.
14116328Dodávky léků – Léčivá látka infliximab k subkutánnímu podání – ATC L04AB02Country: Czech RepublicDeadline31 Aug 20269462970Medicines with the active ingredient infliximab atc l04ab02 - in the dosage form injection solutionCountry: GermanyDeadline31 Aug 20275891073Germany Pharmaceutical products Open house Arzneimittelrabattvertrge Infliximab ATC L04AB02Country: GermanyDeadline05 Sep 20266347219Germany Pharmaceutical products Abschluss nicht exkl Arzneimittel-Rabattvereinb nach 130a Abs 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Infliximab zur subkutanen InCountry: GermanyDeadline31 Dec 20267212275Germany Pharmaceutical products Abschluss nicht-exklusiver Rabattvereinbarungen nach 130 a Abs 8 SGB V mit dem Wirkstoff Infliximab zur intravensen ApplikationCountry: GermanyDeadline10 Feb 20277217961Germany Pharmaceutical products Abschluss nicht-exklusiver Rabattvereinbarungen nach 130 a Abs 8 SGB V mit dem Wirkstoff Infliximab zur subkutanen ApplikationCountry: GermanyDeadline10 Feb 20277429502Germany Pharmaceutical products Abschluss nicht exkl Arzneimittel-Rabattvereinb nach 130a Abs 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Infliximab ATC-Code nach WHOCountry: GermanyDeadline30 Apr 20278231244Germany Pharmaceutical products Abschluss eines nicht exklusiven Rabattvertrages nach 130a Abs 8 SGB V zu Arzneimitteln mit dem Wirkstoff Infliximab ATC-Code L04AB02Country: GermanyDeadline27 May 20279420957Germany Pharmaceutical products Arzneimittel mit dem Wirkstoff Infliximab ATC L04AB02 - in der Darreichungsform Pulver zur Herst eines Infusionslsungskonzentrates oder Pulver frCountry: GermanyDeadline31 Aug 20279436545Germany Pharmaceutical products Arzneimittel mit dem Wirkstoff Infliximab ATC L04AB02 - in der Darreichungsform InjektionslsungCountry: GermanyDeadline31 Aug 20279443811Medicines with the active ingredient infliximab atc l04ab02 - in the dosage form powder for the here of an infusion solution concentrate or powder for a concentrate on the hereCountry: GermanyDeadline31 Aug 202711413501Germany Pharmaceutical products Open house Arzneimittelrabattvertrge zum Wirkstoff Infliximab ATC L04AB02Country: GermanyDeadline31 Jan 202812350304Germany Pharmaceutical products Open house Arzneimittelrabattvertrge zum Wirkstoff Infliximab ATC L04AB02Country: GermanyDeadline31 Jan 202812365692Germany Pharmaceutical products Open house Arzneimittelrabattvertrge zum Wirkstoff Infliximab ATC L04AB02Country: GermanyDeadline31 Mar 202812393233Open house drug discount agreements for the active ingredient infliximab atc l04ab02Country: GermanyDeadline01 Apr 202812491932Germany Pharmaceutical products Open-House-Biologika-Rabattvertrge 2026-11 - Infliximab Darreichungsform zur intravensen AnwendungCountry: GermanyDeadline31 May 202812493589Germany Pharmaceutical products Open-House-Biologika-Rabattvertrge 2026-10 - Infliximab Darreichungsform zur subkutanen InjektionCountry: GermanyDeadline31 May 202812840969Germany Pharmaceutical products Arzneimittel mit dem Wirkstoff Infliximab ATC L04AB02Country: GermanyDeadline30 Apr 202813470112Suministro de Infliximab (DOE)Country: AndorraDeadline20 Sep 202613952187Request for Proposals - Supply of rituximab, infliximab and tocilizumabCountry: New ZealandDeadline02 Sep 202614068576Supply of drugs Infliximab VED STRATEGICALLY IMPORTANTCountry: RussiaDeadline13 Aug 202614156569Supply of a medicinal product for medical use INFLIXIMABCountry: RussiaDeadline11 Aug 202614187817Supply of a medicinal product for medical use InfliximabCountry: RussiaDeadline13 Aug 202614226219Levering van Infliximab voor intraveneuze toedieningCountry: BelgiumDeadline07 Sep 202614248371Supply of Infliximab for intravenous administrationCountry: BelgiumDeadline07 Sep 2026
